Andrew Gengos Joins PBS Biotech® Advisory Board
Camarillo, California, February 23, 2012 – PBS Biotech®, Inc., the leading supplier of novel single-use bioreactors for the biopharmaceutical industry, announced today that Andrew Gengos, President and CEO of Neuraltus Pharmaceuticals, has joined its Advisory Board.
“Andrew’s significant biopharmaceutical industry leadership, strategy and business development experience will be of tremendous value to PBS Biotech as we bring our innovative single-use bioreactor technology to market,” said Brian Lee, Ph.D., CEO and co-founder of PBS Biotech.
Mr. Gengos joined Neuraltus, a privately held biopharmaceutical company dedicated to developing and commercializing products that address critical unmet needs primarily in the treatment of neurodegenerative diseases, as CEO in February 2010. Prior to joining Neuraltus, Mr. Gengos spent more than seven years with Amgen where he was Vice President, Strategy and Corporate Development. He managed Amgen’s in-and-outbound business development activities, including acquisitions, licensing, spin outs, divestitures, corporate venture capital, and alliance management. Before joining Amgen, Mr. Gengos was Vice President, CFO, and CBO of Dynavax Technologies of Berkeley, California, where he was responsible for the company’s business functions including finance and accounting, fundraising, budgeting and planning, and business development. Mr. Gengos has been a Vice President of Strategy at the Chiron Corporation and a Senior Engagement Manager at McKinsey & Company.
“I am delighted to join PBS Biotech’s advisory board. The company has a real opportunity to meaningfully improve biological drug manufacturing processes with its enabling technology,” Gengos said.
Mr. Gengos was awarded his MBA from the Anderson School of Business at UCLA and received his BS degree in Chemical Engineering from MIT.
About PBS Biotech
PBS Biotech, Inc. is a US corporation that designs and manufactures fully scalable and easy to use single-use bioreactors used by global biotechnology organizations. The company has patented innovative industrial designs and advanced software driven control systems that produce low shear cell culture solutions improving operational flexibility and process efficiency, reducing operating costs and accelerating time to market for biotechnology customers. With headquarters in Camarillo, CA., PBS Biotech is a member of the BioProcess Systems Alliance (BPSA).
PBS Biotech, Inc.
Lourie Zak, +1-805-482-7272
Chief Financial Officer